Announcements Trials
Browse Landscape

Status

Completed 55Recruiting 33Unknown 14Active not recruiting 12Terminated 5Not yet recruiting 5Withdrawn 4Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1Head & Neck 1CNS 1Breast 1

Conditions

Breast Neoplasms 1

Interventions

Surgical Procedures, Operative 2Music Therapy 2Letrozole 2Fluorodeoxyglucose F18 2Drug Therapy 2sacituzumab govitecan 1ribociclib 1pembrolizumab 1exemestane 1dalpiciclib 1Zoledronic Acid 1Vitamin D 1Transurethral Resection of Bladder 1Therapeutics 1Tamoxifen 1Synbiotics 1Self-Help Groups 1Resistance Training 1Relaxation Therapy 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Prebiotics 1Oxygen Inhalation Therapy 1Neoadjuvant Therapy 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Mastectomy 1Mannitol 1Mammography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Blood Specimen Collection × Breast × Clear all
NCT01173341 2026-02-09

Cardiotoxicity of Cancer Therapy (CCT)

Abramson Cancer Center at Penn Medicine

Enrolling by invitation
700 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡